South Africa approves trial for oral coronavirus vaccine

Oramed Pharmaceuticals won approval to run an initial clinical trial for its orally delivered Covid-19 vaccine candidate in South Africa.The US-listed company has been given permission by the South African Health Regulatory Products Authority to start enrolling patients in Phase 1 of tests, it said in a statement on Friday. A similar trial is planned in Israel and a Phase 2 trial in the US, Nadav Kidron, Oramed’s chief executive officer, said in an interview. While South Africa has hosted a…

Read the original article at South China Morning Post